Sep 16 2009, 10:50 AM EST
GEN News Highlights
Contract research organization PPD opened a new global central laboratory facility at the Singapore Science Park II. The new site is expected to boost the company’s provision of customizable laboratory services in Southeast Asia.
PPD has operated an office in Singapore for over 10 years to provide clients with clinical development services, clinical trials management monitoring, patient recruitment, and regulatory affairs services. The company says that the new Singapore site houses identical laboratory instrumentation to that at its other global central labs in Brussels, Beijing, and Highland Heights, KY. This will facilitate the cross-validation of assays between all its locations. The Singapore lab will also interface with ConneXion, PPD’s global database.
2009 has already seen PPD acquire AbC.R.O, a contract research organization operating in Central and Eastern Europe. The company separately established a new office in Tokyo to expand its Phase II–IV clinical development services in response to client demand in East Asia. In April PPD also bought Massachusetts-based dermatology therapeutics company, Magen, and announced an agreement to sell its existing Piedmont Research Center to Charles River Laboratories International for $46 million in cash.
♦♦♦
Related News
PPD to Acquire AbCRO (Feb. 9, 2009)
PPD to Invest $18M to Expand Contract Research Operations into Ireland (Dec. 18, 2008)
PPD to Expand Lab Services into Singapore (Dec. 17, 2008)
PPD Expands Eastern European Presence (June 20, 2008)
PPD Plans Further Facility Construction in Scotland (July 30, 2007)
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More GEN News Highlights
Listen
Save
Comment
View All